COVID-19 Impact on Global Psoriatic Arthritis Therapeutics Drug Market Insights, Forecast to 2026
Psoriatic Arthritis Therapeutics Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psoriatic Arthritis Therapeutics Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Psoriatic Arthritis Therapeutics Drug market is segmented into
The Psoriatic Arthritis Therapeutics Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Psoriatic Arthritis Therapeutics Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Psoriatic Arthritis Therapeutics Drug Market Share Analysis
Psoriatic Arthritis Therapeutics Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Psoriatic Arthritis Therapeutics Drug business, the date to enter into the Psoriatic Arthritis Therapeutics Drug market, Psoriatic Arthritis Therapeutics Drug product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Psoriatic Arthritis Therapeutics Drug market is segmented into
- NF Inhibitors
- Interleukin Inhibitors
- PDE4 Inhibitors
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The Psoriatic Arthritis Therapeutics Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Psoriatic Arthritis Therapeutics Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Psoriatic Arthritis Therapeutics Drug Market Share Analysis
Psoriatic Arthritis Therapeutics Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Psoriatic Arthritis Therapeutics Drug business, the date to enter into the Psoriatic Arthritis Therapeutics Drug market, Psoriatic Arthritis Therapeutics Drug product introduction, recent developments, etc.
The major vendors covered:
- AbbVie
- Janssen Biotech
- Novartis
- Amgen
- CELGENE CORPORATION
- Pfizer
- Eli Lilly
- UCB
- Biogen
- Bristol-Myers Squibb
1 STUDY COVERAGE
1.1 Psoriatic Arthritis Therapeutics Drug Product Introduction
1.2 Market Segments
1.3 Key Psoriatic Arthritis Therapeutics Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type
1.4.2 NF Inhibitors
1.4.3 Interleukin Inhibitors
1.4.4 PDE4 Inhibitors
1.4.5 Others
1.5 Market by Application
1.5.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Psoriatic Arthritis Therapeutics Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Psoriatic Arthritis Therapeutics Drug Industry
1.6.1.1 Psoriatic Arthritis Therapeutics Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Psoriatic Arthritis Therapeutics Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Psoriatic Arthritis Therapeutics Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Estimates and Forecasts
2.1.1 Global Psoriatic Arthritis Therapeutics Drug Revenue 2015-2026
2.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales 2015-2026
2.2 Psoriatic Arthritis Therapeutics Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Psoriatic Arthritis Therapeutics Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Psoriatic Arthritis Therapeutics Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PSORIATIC ARTHRITIS THERAPEUTICS DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers
3.1.1 Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2015-2020)
3.1.2 Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers
3.2.1 Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2015-2020)
3.2.2 Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Psoriatic Arthritis Therapeutics Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Drug Revenue in 2019
3.2.5 Global Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Psoriatic Arthritis Therapeutics Drug Price by Manufacturers
3.4 Psoriatic Arthritis Therapeutics Drug Manufacturing Base Distribution, Product Types
3.4.1 Psoriatic Arthritis Therapeutics Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Psoriatic Arthritis Therapeutics Drug Product Type
3.4.3 Date of International Manufacturers Enter into Psoriatic Arthritis Therapeutics Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Type (2015-2020)
4.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020)
4.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2015-2020)
4.1.3 Psoriatic Arthritis Therapeutics Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Type (2021-2026)
4.2.3 Psoriatic Arthritis Therapeutics Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Psoriatic Arthritis Therapeutics Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Application (2015-2020)
5.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020)
5.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2015-2020)
5.1.3 Psoriatic Arthritis Therapeutics Drug Price by Application (2015-2020)
5.2 Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Psoriatic Arthritis Therapeutics Drug by Country
6.1.1 North America Psoriatic Arthritis Therapeutics Drug Sales by Country
6.1.2 North America Psoriatic Arthritis Therapeutics Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
6.3 North America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe Psoriatic Arthritis Therapeutics Drug by Country
7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country
7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
7.3 Europe Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug by Region
8.1.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region
8.1.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
8.3 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Psoriatic Arthritis Therapeutics Drug by Country
9.1.1 Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country
9.1.2 Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
9.3 Central & South America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug by Country
10.1.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country
10.1.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
10.3 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description, Business Overview and Total Revenue
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Products Offered
11.1.5 AbbVie Recent Development
11.2 Janssen Biotech
11.2.1 Janssen Biotech Corporation Information
11.2.2 Janssen Biotech Description, Business Overview and Total Revenue
11.2.3 Janssen Biotech Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Products Offered
11.2.5 Janssen Biotech Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Psoriatic Arthritis Therapeutics Drug Products Offered
11.3.5 Novartis Recent Development
11.4 Amgen
11.4.1 Amgen Corporation Information
11.4.2 Amgen Description, Business Overview and Total Revenue
11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Products Offered
11.4.5 Amgen Recent Development
11.5 CELGENE CORPORATION
11.5.1 CELGENE CORPORATION Corporation Information
11.5.2 CELGENE CORPORATION Description, Business Overview and Total Revenue
11.5.3 CELGENE CORPORATION Sales, Revenue and Gross Margin (2015-2020)
11.5.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Products Offered
11.5.5 CELGENE CORPORATION Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Psoriatic Arthritis Therapeutics Drug Products Offered
11.6.5 Pfizer Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Description, Business Overview and Total Revenue
11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Products Offered
11.7.5 Eli Lilly Recent Development
11.8 UCB
11.8.1 UCB Corporation Information
11.8.2 UCB Description, Business Overview and Total Revenue
11.8.3 UCB Sales, Revenue and Gross Margin (2015-2020)
11.8.4 UCB Psoriatic Arthritis Therapeutics Drug Products Offered
11.8.5 UCB Recent Development
11.9 Biogen
11.9.1 Biogen Corporation Information
11.9.2 Biogen Description, Business Overview and Total Revenue
11.9.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biogen Psoriatic Arthritis Therapeutics Drug Products Offered
11.9.5 Biogen Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Corporation Information
11.10.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.10.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Products Offered
11.10.5 Bristol-Myers Squibb Recent Development
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description, Business Overview and Total Revenue
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Products Offered
11.1.5 AbbVie Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Psoriatic Arthritis Therapeutics Drug Market Estimates and Projections by Region
12.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Regions 2021-2026
12.2 North America Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
12.2.1 North America: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
12.2.2 North America: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
12.2.3 North America: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
12.3.2 Europe: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Psoriatic Arthritis Therapeutics Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Psoriatic Arthritis Therapeutics Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Psoriatic Arthritis Therapeutics Drug Product Introduction
1.2 Market Segments
1.3 Key Psoriatic Arthritis Therapeutics Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type
1.4.2 NF Inhibitors
1.4.3 Interleukin Inhibitors
1.4.4 PDE4 Inhibitors
1.4.5 Others
1.5 Market by Application
1.5.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Psoriatic Arthritis Therapeutics Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Psoriatic Arthritis Therapeutics Drug Industry
1.6.1.1 Psoriatic Arthritis Therapeutics Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Psoriatic Arthritis Therapeutics Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Psoriatic Arthritis Therapeutics Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Estimates and Forecasts
2.1.1 Global Psoriatic Arthritis Therapeutics Drug Revenue 2015-2026
2.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales 2015-2026
2.2 Psoriatic Arthritis Therapeutics Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Psoriatic Arthritis Therapeutics Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Psoriatic Arthritis Therapeutics Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PSORIATIC ARTHRITIS THERAPEUTICS DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers
3.1.1 Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2015-2020)
3.1.2 Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers
3.2.1 Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2015-2020)
3.2.2 Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Psoriatic Arthritis Therapeutics Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Drug Revenue in 2019
3.2.5 Global Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Psoriatic Arthritis Therapeutics Drug Price by Manufacturers
3.4 Psoriatic Arthritis Therapeutics Drug Manufacturing Base Distribution, Product Types
3.4.1 Psoriatic Arthritis Therapeutics Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Psoriatic Arthritis Therapeutics Drug Product Type
3.4.3 Date of International Manufacturers Enter into Psoriatic Arthritis Therapeutics Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Type (2015-2020)
4.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020)
4.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2015-2020)
4.1.3 Psoriatic Arthritis Therapeutics Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Type (2021-2026)
4.2.3 Psoriatic Arthritis Therapeutics Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Psoriatic Arthritis Therapeutics Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Application (2015-2020)
5.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020)
5.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2015-2020)
5.1.3 Psoriatic Arthritis Therapeutics Drug Price by Application (2015-2020)
5.2 Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Psoriatic Arthritis Therapeutics Drug by Country
6.1.1 North America Psoriatic Arthritis Therapeutics Drug Sales by Country
6.1.2 North America Psoriatic Arthritis Therapeutics Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
6.3 North America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe Psoriatic Arthritis Therapeutics Drug by Country
7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country
7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
7.3 Europe Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug by Region
8.1.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region
8.1.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
8.3 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Psoriatic Arthritis Therapeutics Drug by Country
9.1.1 Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country
9.1.2 Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
9.3 Central & South America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug by Country
10.1.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country
10.1.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
10.3 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description, Business Overview and Total Revenue
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Products Offered
11.1.5 AbbVie Recent Development
11.2 Janssen Biotech
11.2.1 Janssen Biotech Corporation Information
11.2.2 Janssen Biotech Description, Business Overview and Total Revenue
11.2.3 Janssen Biotech Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Products Offered
11.2.5 Janssen Biotech Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Psoriatic Arthritis Therapeutics Drug Products Offered
11.3.5 Novartis Recent Development
11.4 Amgen
11.4.1 Amgen Corporation Information
11.4.2 Amgen Description, Business Overview and Total Revenue
11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Products Offered
11.4.5 Amgen Recent Development
11.5 CELGENE CORPORATION
11.5.1 CELGENE CORPORATION Corporation Information
11.5.2 CELGENE CORPORATION Description, Business Overview and Total Revenue
11.5.3 CELGENE CORPORATION Sales, Revenue and Gross Margin (2015-2020)
11.5.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Products Offered
11.5.5 CELGENE CORPORATION Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Psoriatic Arthritis Therapeutics Drug Products Offered
11.6.5 Pfizer Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Description, Business Overview and Total Revenue
11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Products Offered
11.7.5 Eli Lilly Recent Development
11.8 UCB
11.8.1 UCB Corporation Information
11.8.2 UCB Description, Business Overview and Total Revenue
11.8.3 UCB Sales, Revenue and Gross Margin (2015-2020)
11.8.4 UCB Psoriatic Arthritis Therapeutics Drug Products Offered
11.8.5 UCB Recent Development
11.9 Biogen
11.9.1 Biogen Corporation Information
11.9.2 Biogen Description, Business Overview and Total Revenue
11.9.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biogen Psoriatic Arthritis Therapeutics Drug Products Offered
11.9.5 Biogen Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Corporation Information
11.10.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.10.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Products Offered
11.10.5 Bristol-Myers Squibb Recent Development
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description, Business Overview and Total Revenue
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Products Offered
11.1.5 AbbVie Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Psoriatic Arthritis Therapeutics Drug Market Estimates and Projections by Region
12.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Regions 2021-2026
12.2 North America Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
12.2.1 North America: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
12.2.2 North America: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
12.2.3 North America: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
12.3.2 Europe: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Psoriatic Arthritis Therapeutics Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Psoriatic Arthritis Therapeutics Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Psoriatic Arthritis Therapeutics Drug Market Segments
Table 2. Ranking of Global Top Psoriatic Arthritis Therapeutics Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of NF Inhibitors
Table 5. Major Manufacturers of Interleukin Inhibitors
Table 6. Major Manufacturers of PDE4 Inhibitors
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Psoriatic Arthritis Therapeutics Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Psoriatic Arthritis Therapeutics Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Psoriatic Arthritis Therapeutics Drug Players to Combat Covid-19 Impact
Table 13. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Psoriatic Arthritis Therapeutics Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Psoriatic Arthritis Therapeutics Drug Sales by Regions 2015-2020 (K Units)
Table 16. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Psoriatic Arthritis Therapeutics Drug Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Manufacturers (2015-2020)
Table 20. Global Psoriatic Arthritis Therapeutics Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Psoriatic Arthritis Therapeutics Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Therapeutics Drug as of 2019)
Table 22. Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Psoriatic Arthritis Therapeutics Drug Price (2015-2020) (USD/Unit)
Table 25. Psoriatic Arthritis Therapeutics Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Psoriatic Arthritis Therapeutics Drug Product Type
Table 27. Date of International Manufacturers Enter into Psoriatic Arthritis Therapeutics Drug Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 30. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2015-2020)
Table 31. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2015-2020)
Table 33. Psoriatic Arthritis Therapeutics Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 35. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2015-2020)
Table 36. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2015-2020) (K Units)
Table 37. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2015-2020)
Table 38. North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2015-2020)
Table 40. North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 41. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Table 42. North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 43. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Table 44. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2015-2020) (K Units)
Table 45. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2015-2020)
Table 46. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2015-2020)
Table 48. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 49. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Table 50. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 51. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Table 60. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2015-2020) (K Units)
Table 61. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2015-2020)
Table 64. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 65. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Table 66. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 67. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Table 76. AbbVie Corporation Information
Table 77. AbbVie Description and Major Businesses
Table 78. AbbVie Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. AbbVie Product
Table 80. AbbVie Recent Development
Table 81. Janssen Biotech Corporation Information
Table 82. Janssen Biotech Description and Major Businesses
Table 83. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Janssen Biotech Product
Table 85. Janssen Biotech Recent Development
Table 86. Novartis Corporation Information
Table 87. Novartis Description and Major Businesses
Table 88. Novartis Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Novartis Product
Table 90. Novartis Recent Development
Table 91. Amgen Corporation Information
Table 92. Amgen Description and Major Businesses
Table 93. Amgen Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Amgen Product
Table 95. Amgen Recent Development
Table 96. CELGENE CORPORATION Corporation Information
Table 97. CELGENE CORPORATION Description and Major Businesses
Table 98. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. CELGENE CORPORATION Product
Table 100. CELGENE CORPORATION Recent Development
Table 101. Pfizer Corporation Information
Table 102. Pfizer Description and Major Businesses
Table 103. Pfizer Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Pfizer Product
Table 105. Pfizer Recent Development
Table 106. Eli Lilly Corporation Information
Table 107. Eli Lilly Description and Major Businesses
Table 108. Eli Lilly Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Eli Lilly Product
Table 110. Eli Lilly Recent Development
Table 111. UCB Corporation Information
Table 112. UCB Description and Major Businesses
Table 113. UCB Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. UCB Product
Table 115. UCB Recent Development
Table 116. Biogen Corporation Information
Table 117. Biogen Description and Major Businesses
Table 118. Biogen Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Biogen Product
Table 120. Biogen Recent Development
Table 121. Bristol-Myers Squibb Corporation Information
Table 122. Bristol-Myers Squibb Description and Major Businesses
Table 123. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Bristol-Myers Squibb Product
Table 125. Bristol-Myers Squibb Recent Development
Table 126. Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 127. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 131. North America: Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 133. Europe: Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Psoriatic Arthritis Therapeutics Drug Sales Forecast by Region (2021-2026) (K Units)
Table 135. Asia Pacific: Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 137. Latin America: Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 139. Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Psoriatic Arthritis Therapeutics Drug Players
Table 144. Psoriatic Arthritis Therapeutics Drug Customers List
Table 145. Psoriatic Arthritis Therapeutics Drug Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 1. Psoriatic Arthritis Therapeutics Drug Market Segments
Table 2. Ranking of Global Top Psoriatic Arthritis Therapeutics Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of NF Inhibitors
Table 5. Major Manufacturers of Interleukin Inhibitors
Table 6. Major Manufacturers of PDE4 Inhibitors
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Psoriatic Arthritis Therapeutics Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Psoriatic Arthritis Therapeutics Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Psoriatic Arthritis Therapeutics Drug Players to Combat Covid-19 Impact
Table 13. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Psoriatic Arthritis Therapeutics Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Psoriatic Arthritis Therapeutics Drug Sales by Regions 2015-2020 (K Units)
Table 16. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Psoriatic Arthritis Therapeutics Drug Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Manufacturers (2015-2020)
Table 20. Global Psoriatic Arthritis Therapeutics Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Psoriatic Arthritis Therapeutics Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis Therapeutics Drug as of 2019)
Table 22. Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Psoriatic Arthritis Therapeutics Drug Price (2015-2020) (USD/Unit)
Table 25. Psoriatic Arthritis Therapeutics Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Psoriatic Arthritis Therapeutics Drug Product Type
Table 27. Date of International Manufacturers Enter into Psoriatic Arthritis Therapeutics Drug Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 30. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2015-2020)
Table 31. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2015-2020)
Table 33. Psoriatic Arthritis Therapeutics Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 35. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2015-2020)
Table 36. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2015-2020) (K Units)
Table 37. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2015-2020)
Table 38. North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2015-2020)
Table 40. North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 41. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Table 42. North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 43. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Table 44. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2015-2020) (K Units)
Table 45. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2015-2020)
Table 46. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2015-2020)
Table 48. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 49. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Table 50. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 51. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Table 60. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2015-2020) (K Units)
Table 61. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2015-2020)
Table 64. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 65. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Table 66. Latin America Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 67. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Table 76. AbbVie Corporation Information
Table 77. AbbVie Description and Major Businesses
Table 78. AbbVie Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. AbbVie Product
Table 80. AbbVie Recent Development
Table 81. Janssen Biotech Corporation Information
Table 82. Janssen Biotech Description and Major Businesses
Table 83. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Janssen Biotech Product
Table 85. Janssen Biotech Recent Development
Table 86. Novartis Corporation Information
Table 87. Novartis Description and Major Businesses
Table 88. Novartis Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Novartis Product
Table 90. Novartis Recent Development
Table 91. Amgen Corporation Information
Table 92. Amgen Description and Major Businesses
Table 93. Amgen Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Amgen Product
Table 95. Amgen Recent Development
Table 96. CELGENE CORPORATION Corporation Information
Table 97. CELGENE CORPORATION Description and Major Businesses
Table 98. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. CELGENE CORPORATION Product
Table 100. CELGENE CORPORATION Recent Development
Table 101. Pfizer Corporation Information
Table 102. Pfizer Description and Major Businesses
Table 103. Pfizer Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Pfizer Product
Table 105. Pfizer Recent Development
Table 106. Eli Lilly Corporation Information
Table 107. Eli Lilly Description and Major Businesses
Table 108. Eli Lilly Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Eli Lilly Product
Table 110. Eli Lilly Recent Development
Table 111. UCB Corporation Information
Table 112. UCB Description and Major Businesses
Table 113. UCB Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. UCB Product
Table 115. UCB Recent Development
Table 116. Biogen Corporation Information
Table 117. Biogen Description and Major Businesses
Table 118. Biogen Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Biogen Product
Table 120. Biogen Recent Development
Table 121. Bristol-Myers Squibb Corporation Information
Table 122. Bristol-Myers Squibb Description and Major Businesses
Table 123. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Bristol-Myers Squibb Product
Table 125. Bristol-Myers Squibb Recent Development
Table 126. Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 127. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 131. North America: Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 133. Europe: Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Psoriatic Arthritis Therapeutics Drug Sales Forecast by Region (2021-2026) (K Units)
Table 135. Asia Pacific: Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 137. Latin America: Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Sales Forecast by Country (2021-2026) (K Units)
Table 139. Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Psoriatic Arthritis Therapeutics Drug Players
Table 144. Psoriatic Arthritis Therapeutics Drug Customers List
Table 145. Psoriatic Arthritis Therapeutics Drug Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Psoriatic Arthritis Therapeutics Drug Product Picture
Figure 2. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type in 2020 & 2026
Figure 3. NF Inhibitors Product Picture
Figure 4. Interleukin Inhibitors Product Picture
Figure 5. PDE4 Inhibitors Product Picture
Figure 6. Others Product Picture
Figure 7. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Psoriatic Arthritis Therapeutics Drug Report Years Considered
Figure 12. Global Psoriatic Arthritis Therapeutics Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Psoriatic Arthritis Therapeutics Drug Sales 2015-2026 (K Units)
Figure 14. Global Psoriatic Arthritis Therapeutics Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region in 2019
Figure 17. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region in 2019
Figure 19. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Therapeutics Drug Revenue in 2019
Figure 21. Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type in 2019
Figure 24. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type in 2019
Figure 26. Global Psoriatic Arthritis Therapeutics Drug Market Share by Price Range (2015-2020)
Figure 27. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application in 2019
Figure 29. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application in 2019
Figure 31. North America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2019
Figure 34. North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2019
Figure 40. North America Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2019
Figure 41. Europe Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2019
Figure 44. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2019
Figure 45. Germany Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2019
Figure 56. Europe Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2019
Figure 57. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region in 2019
Figure 61. China Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2019
Figure 84. Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2019
Figure 85. Latin America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2019
Figure 88. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2019
Figure 96. Latin America Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2019
Figure 109. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Janssen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. CELGENE CORPORATION Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. North America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Europe Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
Figure 1. Psoriatic Arthritis Therapeutics Drug Product Picture
Figure 2. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type in 2020 & 2026
Figure 3. NF Inhibitors Product Picture
Figure 4. Interleukin Inhibitors Product Picture
Figure 5. PDE4 Inhibitors Product Picture
Figure 6. Others Product Picture
Figure 7. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Psoriatic Arthritis Therapeutics Drug Report Years Considered
Figure 12. Global Psoriatic Arthritis Therapeutics Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Psoriatic Arthritis Therapeutics Drug Sales 2015-2026 (K Units)
Figure 14. Global Psoriatic Arthritis Therapeutics Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region in 2019
Figure 17. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region in 2019
Figure 19. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Therapeutics Drug Revenue in 2019
Figure 21. Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type in 2019
Figure 24. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type in 2019
Figure 26. Global Psoriatic Arthritis Therapeutics Drug Market Share by Price Range (2015-2020)
Figure 27. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application in 2019
Figure 29. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application in 2019
Figure 31. North America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2019
Figure 34. North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2019
Figure 40. North America Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2019
Figure 41. Europe Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2019
Figure 44. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2019
Figure 45. Germany Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2019
Figure 56. Europe Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2019
Figure 57. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region in 2019
Figure 61. China Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2019
Figure 84. Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2019
Figure 85. Latin America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2019
Figure 88. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2019
Figure 96. Latin America Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2019
Figure 109. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Janssen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. CELGENE CORPORATION Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. North America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Europe Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Latin America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
